The increased risk for CAD and cardiovascular disease in CHIP is mediated by increased inflammation through increased IL-1β and IL-6 signaling, particularly in TET2-mutated CHIP (84,88,89). This evidence concerns the gene STUB1 and coronary artery disorder.